The Psychopharmacologists 3 completes a trio of interview-based books about the process of therapeutic innovation in clinical psychiatry. David Healy's method is to interview key individuals involved in the discovery and deployment of drugs that have proved useful to psychiatry, and to draw them together within a model of the mechanism and clinical discovery that he uses as an overall framework.These are historical accounts but highly relevant to the clinical psychiatrist of today, emphasising the importance of research, and of the marketing strategies of pharmaceutical companies in formulating disease entities as well as treatments for them.

Exploring a New World: The Birth of Psychopharmacology A Psychpharmacology That Nearly Was The Psychopharmacology of Life & Death The Catecholamine Hypothesis Catatonia, Pink Sport & Antipsychiatry Receptors & Chemists Receptors & Classical Pharmacology The Receptor Enters Psychiatry 1 The Receptor Enters Psychiatry 2 Visualising Receptors & Beyond From the Presynaptic Neurone to The Receptor to The Nucleus The Discovery of the Psychotropic Effects of Carbamazepine Psychopharmaceuticals in Japan Neurotransmitter Research in Japan Childhood Psychopharmacology Phenomenology, Psychopharmacotherapy & Child Psychiatry From DDT to Imipramine Forty-Four Years of Psychiatry & Psychopharmacology The Neo-Kraepelinian Revolution A Manual for Diagnosis and Statistics Neglected Discipleines in Psychpharmacology: Pharmaco-EEG & Electroshock The Hypnotic Business Angles on Panic From Neuroleptics to Antipsychotics Twenty-First Century Drug Development Ten Years That Changes Psychiatry.